Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy-Reference-Cited by-同舟云学术

Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy

Published:2023-08 Issue:4 Volume:21 Page:430-441
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

von Deimling Markus^ORCID,Schuettfort Victor M.,D'Andrea David^ORCID,Pradere Benjamin^ORCID,Grossmann Nico C.^ORCID,Kawada Tatsushi,Yanagisawa Takafumi,Majdoub Muhammad,Laukhtina Ekaterina^ORCID,Rajwa Pawel,Quhal Fahad,Mostafaei Hadi^ORCID,Fajkovic Harun,Teoh Jeremy Yuen-Chun^ORCID,Moschini Marco,Karakiewicz Pierre I.,Fisch Margit,Rink Michael,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference35 articles.

1. Guidelines on muscle-invasive and metastatic bladder cancer;Witjes,2022

2. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time;Ploussard;Eur Urol,2014

3. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data;Eur Urol,2005

4. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort;Svatek;BJU Int,2011

5. Statistical consideration for clinical biomarker research in bladder cancer;Shariat;Urol Oncol Semin Orig Investig,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of Bladder Cancer;Pharmacogenomics and Personalized Medicine;2024-01

2. High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis;Frontiers in Oncology;2023-11-01